Gensight Biologics SA
PAR:SIGHT
Gensight Biologics SA
PAR:SIGHT
Price:
0.0814
EUR
0.25%
Market Closed
Market Cap:
€18m
Balance Sheet
Balance Sheet Decomposition
Gensight Biologics SA
Gensight Biologics SA
Balance Sheet Decomposition is not available for
Gensight Biologics SA
Gensight Biologics SA
Balance Sheet
Gensight Biologics SA
Gensight Biologics SA
Currency: EUR
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
17
|
11
|
30
|
54
|
55
|
26
|
19
|
38
|
44
|
11
|
2
|
2
|
|
| Cash |
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
2
|
2
|
|
| Cash Equivalents |
15
|
9
|
30
|
54
|
55
|
26
|
19
|
38
|
44
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
2
|
4
|
3
|
5
|
5
|
6
|
4
|
5
|
4
|
2
|
2
|
|
| Accounts Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
|
| Other Receivables |
1
|
1
|
4
|
3
|
5
|
5
|
6
|
4
|
4
|
4
|
2
|
2
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
1
|
3
|
2
|
2
|
4
|
9
|
2
|
1
|
|
| Total Current Assets |
18
|
14
|
35
|
58
|
61
|
35
|
28
|
44
|
53
|
23
|
7
|
5
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
1
|
1
|
4
|
3
|
3
|
2
|
2
|
1
|
|
| PP&E Gross |
0
|
0
|
1
|
1
|
1
|
1
|
4
|
3
|
3
|
2
|
2
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
4
|
5
|
4
|
5
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
4
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
19
N/A
|
15
-21%
|
36
+145%
|
59
+63%
|
62
+5%
|
37
-41%
|
32
-12%
|
47
+46%
|
57
+20%
|
26
-54%
|
9
-65%
|
11
+18%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
1
|
2
|
5
|
2
|
2
|
8
|
7
|
8
|
12
|
8
|
6
|
6
|
|
| Accrued Liabilities |
0
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
2
|
4
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
5
|
2
|
17
|
14
|
|
| Other Current Liabilities |
0
|
1
|
1
|
0
|
0
|
0
|
2
|
4
|
3
|
1
|
0
|
0
|
|
| Total Current Liabilities |
2
|
4
|
6
|
3
|
4
|
10
|
12
|
17
|
22
|
15
|
25
|
23
|
|
| Long-Term Debt |
0
|
1
|
1
|
3
|
3
|
3
|
10
|
16
|
12
|
15
|
6
|
5
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
6
|
11
|
8
|
10
|
|
| Total Liabilities |
2
N/A
|
4
+122%
|
7
+65%
|
6
-16%
|
7
+23%
|
13
+82%
|
22
+68%
|
36
+62%
|
41
+14%
|
41
+1%
|
40
-3%
|
38
-5%
|
|
| Equity | |||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
|
| Retained Earnings |
2
|
9
|
21
|
38
|
58
|
89
|
118
|
142
|
166
|
198
|
223
|
237
|
|
| Additional Paid In Capital |
19
|
19
|
50
|
91
|
112
|
112
|
128
|
153
|
181
|
181
|
191
|
207
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
17
N/A
|
11
-38%
|
29
+177%
|
53
+82%
|
55
+3%
|
24
-57%
|
11
-56%
|
12
+12%
|
16
+36%
|
15
N/A
|
31
-101%
|
27
+12%
|
|
| Total Liabilities & Equity |
19
N/A
|
15
-21%
|
36
+145%
|
59
+63%
|
62
+5%
|
37
-41%
|
32
-12%
|
47
+46%
|
57
+20%
|
26
-54%
|
9
-65%
|
11
+18%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
0
|
14
|
14
|
19
|
24
|
24
|
33
|
41
|
46
|
46
|
65
|
124
|
|
Switch to:
Switch to:
See Also
Discover More
